U.S. Stock News

Keurig Dr Pepper stock has fallen about 9.9% over the past year, yet the broader valuation checks currently lean on the expensive side rather than flagging a clear bargain. The roughly 9.9% share price decline over 1 year suggests investors have cooled on the story despite the company staying active with growth initiatives. Ongoing integration of the JDE Peet’s acquisition and progress toward a future separation of the business can support revenue and profit expectations, but any stumble in...

CleanSpark has now reported its fiscal third-quarter 2026 results, swinging from net income of US$257.39 million a year ago to a net loss of US$239.84 million, while separately confirming July bitcoin production of 586 coins. At the same time, the company has outlined a long-term shift toward digital infrastructure by securing a 20‑year, US$6.60 billion triple‑net lease for its Sandersville, Georgia AI data center campus with an investment‑grade technology tenant. We’ll now explore how this...

Why Haemonetics Stock Is Back in Focus After Q1 Earnings Haemonetics (HAE) has attracted fresh attention after first quarter revenue of US$339.38 million, higher earnings per share from continuing operations, and a raised fiscal 2027 revenue outlook, along with stronger cash generation and debt repayment. See our latest analysis for Haemonetics. Haemonetics' recent Q1 update, stronger cash generation and fresh product evidence around its VASCADE MVP XL system have come alongside a 90 day...

Merck (NYSE:MRK) and Gilead Sciences have stopped a Phase III trial combining Trodelvy and Keytruda in non small cell lung cancer after interim data disappointed. The decision ends development of this specific Keytruda and Trodelvy combination in this cancer setting. The move affects expectations for Merck's oncology pipeline, where combination therapies with Keytruda play an important role. Consider broadening your research to other large cap drug makers and healthcare stocks with more...

JBT Marel (JBTM) has just given investors fresh information to work with, pairing a declared quarterly dividend of $0.10 per share with second quarter 2026 results and updated full year earnings guidance. See our latest analysis for JBT Marel. At a share price of $123.12, JBT Marel has seen short term weakness, with a 7 day share price return down 11.09% and a year to date share price return down 18.24%, while the 3 year total shareholder return of 11.46% highlights a different picture over a...

Atlanta Braves Holdings, Inc. reported second-quarter 2026 results showing revenue of US$305.12 million, down from US$312.44 million a year earlier, and moved from net income to a net loss of US$12.23 million, with basic and diluted loss per share of US$0.19 from continuing operations. Over the first half of 2026, the company increased revenue to US$377.13 million from US$359.65 million, but its net loss widened to US$52.72 million and loss per share from continuing operations rose to...

Why Venture Global Stock Is Drawing Attention Now Venture Global (VG) has been attracting fresh attention after recent share price moves, with the stock closing at $13.26 and posting mixed short term returns alongside stronger figures over the past 3 months and year to date. See our latest analysis for Venture Global. Despite a softer 1 day share price return of 2.36% and a 7 day share price return that is also slightly lower, Venture Global has recently shown stronger momentum, with its 30...

Kraft Heinz stock sits at a curious point for valuation minded investors. The share price has declined over the past five years, yet the current intrinsic value estimate based on a Discounted Cash Flow (DCF) approach suggests the stock trades at a large discount, while broader checks point to a more mixed picture. Over the past five years, Kraft Heinz shares are down about 14%, which means recent holders have seen capital value erode even before considering dividends. The company is...

Douglas Emmett (DEI) is back in focus after its second quarter 2026 earnings update, which showed modestly higher revenue, a smaller net loss and refreshed guidance tied to leasing performance and debt refinancing. See our latest analysis for Douglas Emmett. Douglas Emmett’s latest earnings update has come after a mixed period for investors, with the share price up 5.6% year to date but the 1 year total shareholder return down 13.45%. The modest 1 day share price gain of 1.65% around the time...

Rocket Companies (RKT) drew investor attention after releasing second quarter 2026 results, reporting revenue of US$2.78b and net income of US$230 million, compared with a small loss a year earlier. See our latest analysis for Rocket Companies. Rocket Companies’ share price has reacted positively to the earnings release in the very short term, with a 1 day share price return of 3.78% and 7 day share price return of 6.36%. However, the year to date share price return is down 30.99%, while the...

Why Iovance Biotherapeutics Stock Is Back in Focus After Q2 Earnings Iovance Biotherapeutics (IOVA) is back on investors radar after reporting second quarter 2026 results. The company posted higher revenue, a smaller net loss and reaffirmed full year revenue guidance in the US$350 million to US$370 million range. See our latest analysis for Iovance Biotherapeutics. The latest Q2 report and reaffirmed revenue outlook have arrived after a strong run in Iovance Biotherapeutics share price, with...

A sudden mobile outage that left thousands of Verizon, AT&T and T-Mobile customers without reliable service has thrown a spotlight on how vulnerable everyday connectivity can feel. When networks falter, reputations and revenue are both at risk, which can quickly reshape how investors view telecom related stocks. This article walks through 3 stocks exposed to the news, all with potential downside to consider, so you can judge whether the risk is worth your capital. Verizon Communications...

BioNTech (NasdaqGS:BNTX) cut its 2026 revenue guidance to a range of €1,600 million to €1,900 million from €2,000 million to €2,300 million. The update followed second quarter results, which showed higher losses and lower sales. See our latest analysis for BioNTech. BioNTech's share price has moved to $93.67 after the guidance cut and wider earnings release, with a 7 day share price return of 3.41% and a year to date share price return that is down 3.12%. Over a longer window, momentum has...

NextNav’s 5G PNT Deal With Safran NextNav (NN) drew investor attention after announcing an agreement with Safran Electronics & Defense to integrate its terrestrial 5G positioning, navigation, and timing network with Safran’s timing and navigation receiver in Santa Clara County. The collaboration focuses on testing how 5G powered 3D PNT signals can complement GPS and other GNSS technologies for drones, autonomous systems, public safety, and critical infrastructure that rely on assured...

Madrigal Pharmaceuticals, Inc. reported second-quarter 2026 results showing a net loss of US$57.94 million, up from US$42.28 million a year earlier, and a six-month net loss of US$152.33 million versus US$115.52 million previously. This widening loss profile highlights the cost intensity of scaling its MASH-focused business at a time when investors are closely watching progress toward profitability. Next, we’ll examine how this larger quarterly net loss shapes Madrigal’s existing investment...

Capital Clean Energy Carriers Corp. recently reported second-quarter 2026 results showing higher sales year-on-year, continued vessel deliveries including the LNG carrier Alcaios I, and announced a new two‑year US$20.0 million share repurchase program under which it has already bought back 99,411 shares for US$2.14 million. Together with ongoing dividend payments and a reported contract backlog that could reach into the billions with options, these moves highlight management’s focus on...

US 10 year yields fell after a weaker jobs report in July, and that gives founder led companies a different kind of spotlight. When money is less rewarded just for sitting in bonds, investors often look harder at leaders who have real skin in the game and tight control of capital. This article explains how that potential edge works today and highlights 3 stocks from the Top Founder Led Companies screener. The three founder led stocks covered below are just a sample, and the full screen...

Radian Group stock reacts to Q2 results and recent buybacks Radian Group (RDN) is back in focus after second quarter 2026 results highlighted strong revenue, resilient mortgage insurance trends, and the first full quarter contribution from specialty insurer Inigo, alongside ongoing share repurchases. See our latest analysis for Radian Group. Radian Group's latest report and buyback activity land against a mixed share price backdrop, with a 1 day share price return of 1.79% but a 7 day share...

Cactus, Inc. reported past second-quarter 2026 results with revenue of US$449.53 million and net income of US$49 million, alongside a 7% increase in its quarterly dividend to US$0.15 per Class A share and the appointment of industry veteran Joseph Elkhoury to its expanded Board. However, management’s expectation that third-quarter revenue will be slightly lower than the second quarter introduces a more cautious near-term outlook despite the strong recent performance and higher shareholder...

In early August 2026, Heritage Insurance Holdings, Inc. reported second-quarter 2026 results showing revenue of US$214.2 million and net income of US$61.71 million, alongside the completion of a buyback of 555,024 shares for US$12.53 million. The combination of higher earnings, improved underwriting metrics, and active share repurchases highlights management’s focus on profitability and capital efficiency in a catastrophe-exposed insurance portfolio. We’ll now examine how this stronger...

Why CorVel’s Latest Earnings Matter For Investors CorVel (CRVL) reported first quarter 2026 results on 5 August, with higher sales, net income, and earnings per share compared with the same period a year earlier, drawing fresh attention to the stock. The company also updated investors on recent share repurchases alongside the earnings release. This adds another factor for you to weigh when assessing CorVel’s valuation and longer term return potential. See our latest analysis for...

Atmus Filtration Technologies just saw its stock drop about 6% in a single session, yet the earnings story reads very differently. Q2 revenue reached about US$528m with adjusted earnings per share near US$0.82, and adjusted EBITDA margin sat just over 20%. For an industrial filtration business, that combination of scale and profitability is the real headline. The market is reacting to the shock of the price move, while the fundamentals point to a company that just reported one of its...

Why BKV stock is back in focus after the latest quarterly update BKV (BKV) moved back onto investor watchlists after reporting record adjusted earnings for the June quarter, with upstream production at the high end of guidance and fresh capital plans for power projects. See our latest analysis for BKV. The latest earnings and production updates have put BKV back in the spotlight, yet the share price tells a more cautious story. The 90 day share price return declined 13.69% and the year to...

O'Reilly Automotive, Inc. recently reported second-quarter 2026 results showing higher sales of US$4.89 billion and increased net income of US$715.06 million, raised its full-year 2026 revenue and earnings guidance, completed a large share repurchase program, and outlined a preference for smaller tuck-in acquisitions over large deals. The combination of stronger earnings, more optimistic full-year guidance, and disciplined capital allocation through buybacks and selective acquisitions...